Stoke Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Stoke Therapeutics, Inc.‘s stocks are currently a part of 57 hedge funds’ portfolios, which represents 37.26% of the total amount of its stocks outstanding. This makes up a total of 14.49M shares of Stoke Therapeutics, Inc.. Compared to the previous quarter, the number fell by -64.02% or -25.79M shares fewer. As for the holding position changes, 36.84% (21) of current hedge fund investors increased the number of shares held, 36.84% (21) of current holders sold a part of the shares held, and 15.79% (9) closed the holdings completely. 2 hedge funds are new holders of Stoke Therapeutics, Inc. stock in Q1 2023, it is 3.51% of total holders.
Hedge funds holding Stoke Therapeutics (Q2 2019 – Q1 2023)
| Q2 2019 | 47 |
|---|---|
| Q3 2019 | 52 |
| Q4 2019 | 63 |
| Q1 2020 | 66 |
| Q2 2020 | 69 |
| Q3 2020 | 86 |
| Q4 2020 | 90 |
| Q1 2021 | 102 |
| Q2 2021 | 95 |
| Q3 2021 | 88 |
| Q4 2021 | 93 |
| Q1 2022 | 98 |
| Q2 2022 | 90 |
| Q3 2022 | 101 |
| Q4 2022 | 106 |
| Q1 2023 | 57 |
Hedge funds changes in Stoke Therapeutics positions (Q2 2019 – Q1 2023)
| Q2 2019 | 47 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2019 | 24 | 13 | 9 | 19 | -13 |
| Q4 2019 | 15 | 26 | 11 | 4 | 7 |
| Q1 2020 | 12 | 29 | 15 | 9 | 1 |
| Q2 2020 | 9 | 17 | 23 | 6 | 14 |
| Q3 2020 | 22 | 16 | 28 | 5 | 15 |
| Q4 2020 | 16 | 31 | 25 | 11 | 7 |
| Q1 2021 | 25 | 32 | 25 | 12 | 8 |
| Q2 2021 | 11 | 41 | 26 | 17 | 0 |
| Q3 2021 | 8 | 26 | 30 | 15 | 9 |
| Q4 2021 | 20 | 32 | 25 | 15 | 1 |
| Q1 2022 | 20 | 35 | 26 | 15 | 2 |
| Q2 2022 | 10 | 40 | 20 | 14 | 6 |
| Q3 2022 | 17 | 35 | 30 | 7 | 12 |
| Q4 2022 | 15 | 42 | 33 | 11 | 5 |
| Q1 2023 | 2 | 21 | 21 | 9 | 4 |
Hedge funds changes in Stoke Therapeutics stock options (Q2 2019 – Q1 2023)
| Q2 2019 | 0 | 0 |
|---|---|---|
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 608,000 | 5,000 |
| Q3 2020 | 1,479,000 | 0 |
| Q4 2020 | 4,777,000 | 507,000 |
| Q1 2021 | 2,995,000 | 4,463,000 |
| Q2 2021 | 1,721,000 | 1,087,000 |
| Q3 2021 | 336,000 | 745,000 |
| Q4 2021 | 0 | 0 |
| Q1 2022 | 3,323,000 | 0 |
| Q2 2022 | 514,000 | 3,000 |
| Q3 2022 | 308,000 | 5,567,000 |
| Q4 2022 | 182,754 | 40,612 |
| Q1 2023 | 16,665,000 | 0 |